Jialun Wang

Dr. Jialun Wang

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2022 in Cancers
Verified
Journal Article
Open access
PDF file
YCYu Chen
Yu Chen
JWJialun Wang
Jialun Wang
QGQiyuan Guo
Qiyuan Guo
XLXihan Li
Xihan Li
XZXiaoping Zou
Xiaoping Zou
The molecular mechanism that promotes pancreatic cancer remains unclear, so it is important to find the molecular network of important genes related to pancreatic cancer. To find the key molecule of pancreatic cancer, differential gene expression analyses were analyzed by the Deseq2 package, edgeR package, and limma-voom package, respectively. Pancreatic cancer survival-related genes were analyzed by COX survival analysis. Finally, we integrated the results to obtain the significantly differentially expressed gene, MYEOV (myeloma overexpressed gene), most strongly related to survival in pancreatic cancer. Experimental verification by qRT-PCR confirmed that transcription levels of MYEOV mRNA markedly increased in pancreatic cancer cells relative to normal human pancreatic ductal epithelial cells (HPDE). Through the comprehensive analysis of multiple databases, we constructed a molecular network centered on MYEOV and found specific links between molecules in this network and tumor-associated immune cells. It was noted that MYEOV could serve as a ceRNA by producing molecular sponging effects on hsa-miR-103a-3p and hsa-miR-107, thus affecting the role of GPRC5A, SERPINB5, EGFR, KRAS, EIF4G2, and PDCD4 on pancreatic cancer progression. Besides, we also identified that infiltrated immune cells are potential mediators for the molecules in the MYEOV-related network to promote pancreatic cancer progression. It is the first report to focus on the possibility that MYEOV may act as a competing endogenous RNA (ceRNA) to form an interactive network with some pancreatic cancer-related genes such as KRAS and serve as a key therapeutic target of pancreatic cancer treatment.

17 July 2025 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Open access
ACAotian Chen
Aotian Chen
JWJialun Wang
Jialun Wang
JYJiaying Yang
Jiaying Yang
YWYue Wang
Yue Wang
CWChenchen Wu
Chenchen Wu
XZXiaoping Zou
Xiaoping Zou
As a highly malignant tumor, pancreatic adenocarcinoma (PAAD) has nonspecific symptoms and a poor prognosis. Previous studies have demonstrated that perineural invasion (PNI) and neurotrophic factors (NFs) play essential roles in PAAD. Nevertheless, the prognostic significance and functions of NF-related genes (NFRGs) in PAAD remain unclear. In this research, we conducted an intersection analysis utilizing differentially expressed genes (DEGs) found in the TCGA-PAAD cohort along with NFRGs from the Genecard. Using machine learning (ML) techniques, including LASSO regression, SVM-RFE and random forest algorithms, we developed a highly accurate prognostic model centered on NFRGs, ultimately pinpointing BCL11A as the crucial prognostic NFRG. Via analysis of the TCGA cohort, immunohistochemistry of 20 pairs of clinical samples and western blot of PAAD cell lines, BCL11A was found to be low-expressed in PAAD and associated with a poor prognosis. Experiments conducted both in vitro and in vivo revealed that the increased expression of BCL11A suppressed tumor growth and triggered apoptosis through endoplasmic reticulum (ER) stress. Moreover, immune infiltration analysis found increased CD8+ T cells in the BCL11Ahigh group. Flow cytometry demonstrated that overexpression of BCL11A in vivo promoted intratumoral CD8+ T cell infiltration and activation, and increased PD-L1 expression. Our study confirmed BCL11A as a potential biomarker of clinical prognosis, immune infiltration, and neural-tumor interactions in PAAD, and might provide new insights for diagnosis and treatment of this tumor.